Today: 7 February 2026
Subscribe
Browse Category

NSE:INFY.NS News 12 January 2026 - 17 January 2026

Infosys stock price jumps after FY26 guidance lift — what investors watch next week

Infosys stock price jumps after FY26 guidance lift — what investors watch next week

Infosys shares jumped 5.6% to 1,689.80 rupees Friday after the company raised its FY26 revenue growth forecast to 3–3.5%. The Nifty 50 and Sensex edged higher, led by IT stocks. Wipro and Tech Mahindra posted mixed results, with Wipro’s deal bookings at a six-quarter low. Indian markets were closed Thursday for elections and will shut again Jan. 26 for Republic Day.
17 January 2026
·
India stock market today: Sensex, Nifty snap five-day slide after late rebound on trade-talk cue

India stock market today: Sensex, Nifty snap five-day slide after late rebound on trade-talk cue

India’s Sensex rose 0.36% and the Nifty 0.42% on Monday, snapping a five-day losing streak after rebounding from early lows. Over 360 stocks hit 52-week lows despite the benchmark gains. Tata Consultancy Services beat revenue estimates but posted a 14% profit drop on restructuring costs. December retail inflation rose to 1.33% year-on-year, below forecasts.
12 January 2026
······

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop